Thumbnail
Access Restriction
Open

Author Goswami, Sumanta Kumar ♦ Inceoglu, Bora ♦ Yang, Jun ♦ Wan, Debin ♦ Kodani, Sean D. ♦ Trindade da Silva, Carlos Antonio ♦ Morisseau, Christophe ♦ Hammock, Bruce D.
Source United States Department of Energy Office of Scientific and Technical Information
Content type Text
Language English
Subject Keyword APPLIED LIFE SCIENCES ♦ ANALGESICS ♦ ARACHIDONIC ACID ♦ CATABOLISM ♦ CYTOCHROMES ♦ EPOXIDES ♦ GLYCOLS ♦ HYDROLASES ♦ INFLAMMATION ♦ INHIBITION ♦ LIVER ♦ METABOLITES ♦ MICROSOMES ♦ PAIN ♦ PROSTAGLANDINS ♦ RATS ♦ SENSITIVITY ♦ TIME DEPENDENCE
Abstract Epoxyeicosatrienoic acids (EETs) are potent endogenous analgesic metabolites produced from arachidonic acid by cytochrome P450s (P450s). Metabolism of EETs by soluble epoxide hydrolase (sEH) reduces their activity, while their stabilization by sEH inhibition decreases both inflammatory and neuropathic pain. Here, we tested the complementary hypothesis that increasing the level of EETs through induction of P450s by omeprazole (OME), can influence pain related signaling by itself, and potentiate the anti-hyperalgesic effect of sEH inhibitor. Rats were treated with OME (100 mg/kg/day, p.o., 7 days), sEH inhibitor TPPU (3 mg/kg/day, p.o.) and OME (100 mg/kg/day, p.o., 7 days) + TPPU (3 mg/kg/day, p.o., last 3 days of OME dose) dissolved in vehicle PEG400, and their effect on hyperalgesia (increased sensitivity to pain) induced by PGE{sub 2} was monitored. While OME treatment by itself exhibited variable effects on PGE{sub 2} induced hyperalgesia, it strongly potentiated the effect of TPPU in the same assay. The significant decrease in pain with OME + TPPU treatment correlated with the increased levels of EETs in plasma and increased activities of P450 1A1 and P450 1A2 in liver microsomes. The results show that reducing catabolism of EETs with a sEH inhibitor yielded a stronger analgesic effect than increasing generation of EETs by OME, and combination of both yielded the strongest pain reducing effect under the condition of this study. - Highlights: • The soluble epoxide hydrolase (sEH) inhibitor TPPU is anti-hyperalgesic. • Omeprazole potentiates the anti-hyperalgesic actions of TPPU. • This potentiation is associated with increased P450 activity. • The potentiation is associated with an increase in fatty acid epoxide/diol ratio. • Joint use of sEH inhibitors and P450 inducers could result in drug–drug interactions.
ISSN 0041008X
Educational Use Research
Learning Resource Type Article
Publisher Date 2015-12-15
Publisher Place United States
Journal Toxicology and Applied Pharmacology
Volume Number 289
Issue Number 3


Open content in new tab

   Open content in new tab